GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models

Shanchun Guo, Changde Zhang, Madhusoodanan Mottamal, Ahamed Hossain, Jiawang Liu, Guangdi Wang

Breast Cancer Research and Treatment · 2020 · 12 citations · 33 references

DOIFull text

Open access

Concepts

References

33